Manufacturing and Production

Showing 15 posts of 5862 posts found.

shutterstock_159488225

Farxiga smashes all goals in Phase 3 chronic kidney disease trial, says AstraZeneca

July 28, 2020 Manufacturing and Production, Research and Development AstraZeneca, farxiga

AstraZeneca has teased new data from a Phase 3 study of its sodium-glucose co-transporter-2 (SGLT2) inhibitor Farxiga (dapagliflozin) in the …
shutterstock_38078521

Kyowa Kirin’s Crysvita secures CHMP support in rare X-linked hypophosphataemia

July 28, 2020 Manufacturing and Production, Sales and Marketing CHMP, EMA

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has given its backing to Kyowa Kirin’s …
celltrion1

Celltrion’s infliximab biosimilar Remsima secures European approval in five indications

July 27, 2020 Manufacturing and Production, Sales and Marketing celltrion, infliximab, pharma, remsima

The subcutaneous (SC) formulation of Remsima, Celltrion’s biosimilar version of infliximab, has secured approval from the European Commission covering five …
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …
meekey

David Meeker appointed Chief Executive Officer of Rhythm Pharmaceuticals

July 23, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company. Meeker succeeds interim …
shutterstock_244903099

UK Government invests £100m in new COVID-19 vaccine manufacturing site

July 23, 2020 Manufacturing and Production, Research and Development COVID-19, UK, Vaccine, coronavirus

The UK Government’s Department for Business, Energy & Industrial Strategy has revealed a new pledge of an additional £100 million …
shutter

Acadia’s pimavanserin falls short at Phase 3 in major depressive disorder

July 21, 2020 Manufacturing and Production, Research and Development Acadia Pharmaceuticals, major depressive disorder, phase 3, trial failure

Acadia Pharmaceuticals has lifted the lid on new Phase 3 for its therapy pimavanserin, revealing that the drug unfortunately failed …
vaccinessssssssssssssssssss_1

India begins human trials of its first homegrown coronavirus vaccine

July 21, 2020 Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus

India has begun human trials of its first internally developed vaccine for COVID-19. The Indian Council of Medical Research have …
512px-oxford_university_colleges-all_souls1

AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data

July 21, 2020 Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus

Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …
stock_image_drugs

Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait

July 21, 2020 Manufacturing and Production COVID-19, Fujifilm, Japan, avigan, coronavirus

Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait. The trials will be …

North Korea says it’s developing its own coronavirus vaccine

July 21, 2020 Manufacturing and Production COVID-19, North Korea, coronavirus

North Korea has announced it is developing a vaccine against COVID-19. The announcement was made on 18 July by the …

Is Pharma doing enough on sustainability?

July 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …

Innate Pharma announces new Executive Vice President and Chief Medical Officer

July 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Innate Pharma, appointment

Innate Pharma has named Dr Joyson Karakunnel as its new Executive Vice President and Chief Medical Officer (CMO), with current …
masksss

People in England must wear face mask in shops from 24 July

July 14, 2020 Manufacturing and Production coronavirus, masks

Face masks are set to become mandatory in shops across England beginning on 24 July, following months of mixed messaging …
shutter

Malaria prophylactic tafenoquine shows antiviral activity against SARS-CoV-2 in cell cultures

July 14, 2020 Manufacturing and Production, Research and Development 60 Degrees Pharmaceuticals, COVID-19, coronavirus, pharma

Specialist tropical disease drug firm 60 Degrees Pharmaceuticals has revealed that its therapy Arakoda (tafenoquine) has been shown in cell …
The Gateway to Local Adoption Series

Latest content